Latest news with #MichaelShea
Travel Daily News
19-05-2025
- Business
- Travel Daily News
Bradley International Airport partners with GoodMaps
Bradley International Airport becomes Connecticut's first airport to launch GoodMaps, enhancing accessibility for disabled, neurodiverse, and non-English-speaking travelers. WINDSOR LOCKS, CONN – The Connecticut Airport Authority (CAA) announce on this Global Accessibility Awareness Day that Bradley International Airport (BDL) is the first airport in Connecticut to launch GoodMaps, an indoor navigation and digital mapping app that's designed to make the travel experience easier for passengers with certain disabilities. GoodMaps wayfinding allows for greater accessibility in the airport environment and is designed for passengers who are blind, deaf, neurodiverse or non-English speaking. It can also be used by first-time fliers or those unfamiliar with the airport setting. Using the app, passengers will be able to navigate their way through BDL by following precise indoor navigation. This technology will help users maneuver through the terminal space more confidently, while helping to minimize any anxiety or unknowns related to the travel experience. 'We are proud of the partnership between Bradley International Airport and GoodMaps,' said Michael W. Shea, Executive Director of the Connecticut Airport Authority. 'Together we are helping to ensure that everyone who comes through Bradley International has a seamless travel experience.' The GoodMaps platform uses advanced mapping technology to create a highly detailed three-dimensional layout of BDL's terminal. GoodMaps then provides step-by-step and turn-by-turn directions to airline ticket counters, TSA security checkpoints, gates, restrooms, baggage claim, dining, shopping, and more. The GoodMaps app offers these key accessibility features: Audio and visual guidance tailored to passengers who are blind, low vision, deaf, or hard-of-hearing Step-free routing to all amenities and services for passengers with limited mobility Multilingual support for international passengers in more than 18 languages Real-time updates that reflect any airport changes Passengers can download GoodMaps for free on IOS or Android.
Reuters
18-03-2025
- Business
- Reuters
20 US states balk at Florida settlement with drugmaker Sandoz
March 18 (Reuters) - Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision could restrict damages claims in other lawsuits. The states, along with the District of Columbia and U.S. Virgin Islands, in a court filing, opens new tab on Monday challenged a part of Florida's settlement that they said could bar other states from settling for more than Florida did, for up to four years. Florida's settlement, opens new tab with Sandoz in federal court in Connecticut resolved the state's claims that the company participated in a broad price-fixing conspiracy. Sandoz is among many pharmaceutical defendants and has denied any wrongdoing. Sandoz makes drugs including antidepressants amitriptyline and clomipramine, and clobetasol, which is used to treat some skin conditions. Florida and Connecticut, a lead state in the antitrust litigation, did not immediately respond to requests for comment. U.S. District Judge Michael Shea has not ruled on the states' opposition to Florida's settlement. The states asked the judge to strike the provision that they said could curtail future settlement amounts. Sandoz in a statement on Tuesday said Florida represented one of the largest claims made by any plaintiff state in the litigation. Sandoz said the settlement 'shows that we are willing to resolve matters when it is in the interest of the company to do so.' Connecticut and the other states said Florida's settlement, which was inked in January, gives Sandoz 'unfair leverage in settlement negotiations with the remaining states.' The states in Monday's court filing said Sandoz was 'attempting to substantially limit their liability in this case.' Sandoz has settled other claims in the wide-ranging multidistrict litigation. In February, Sandoz agreed to pay $275 million to resolve claims by U.S. consumers and others who accused the company of conspiring with industry rivals to illegally fix prices. Sandoz last year agreed to pay $265 million to resolve related claims lodged in the litigation by a group of wholesale drug purchasers and others. The case is State of Connecticut et al v. Sandoz, U.S. District Court, District of Connecticut, No. 3:20-cv-00802-MPS.
